SCHEMBL3436581

SCHEMBL3436581

Cc1cc(Cl)c(F)c(CC#N)c1N1CCN(CC(N)=O)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.38
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
SCN9A Q15858 1/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
LMNA P02545 4/20 0.35
GLA P06280 1/20 0.35
RAB9A P51151 1/20 0.35
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
AOC3 Q16853 2/20 0.33
NPSR1 Q6W5P4 1/20 0.32
MAPT P10636 3/20 0.32
L3MBTL1 Q9Y468 2/20 0.31
HTT P42858 1/20 0.31
CHRM5 P08912 1/20 0.31
CHRM1 P11229 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3434444 0.88 HSP90AA1 (0.36) ALDH1A1HSP90AA1HSP90AB1SCN9ASMN1; SMN2
SCHEMBL13999802 0.86 HSP90AA1 (0.38) ALDH1A1HSP90AA1HSP90AB1SCN9ASMN1; SMN2
SCHEMBL3436005 0.83 MAPK1 (0.36) ALDH1A1HSP90AA1HSP90AB1SCN9ALMNA
SCHEMBL3556808 0.76 AOC3 (0.41) ALDH1A1CYP1A2CYP3A4GAACYP2C9
SCHEMBL3436523 0.74 ALDH1A1 (0.41) ALDH1A1CYP1A2CYP3A4GAACYP2C9
SCHEMBL3436531 0.74 AOC3 (0.39) ALDH1A1SCN9ALMNACYP1A2CYP3A4
SCHEMBL3436488 0.71 CYP1A2 (0.42) ALDH1A1SCN9ACYP1A2CYP3A4GAA
SCHEMBL14000118 0.71 ALDH1A1 (0.32) ALDH1A1MAPT
SCHEMBL3436197 0.70 CYP1A2 (0.38) CYP1A2CYP3A4GAACYP2C9CYP2C19
SCHEMBL13999570 0.69 ALDH1A1 (0.38) ALDH1A1CYP1A2CYP3A4GAACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163746-B2 Azolecarboxamide derivative ASTELLAS PHARMA INC. (JP) 2012-04-24 US disclosed
US-8163746-B2 Azolecarboxamide derivative ASTELLAS PHARMA INC. (JP) 2012-04-24 US disclosed
US-20090286766-A1 AZOLECARBOXAMIDE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2009-11-19 US disclosed
US-20090286766-A1 AZOLECARBOXAMIDE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286766-A1 AZOLECARBOXAMIDE DERIVATIVE GPR17, NTRK1, TRPV1 ALDH1A1 975/4885HSP90AA1 3446/4885HSP90AB1 3216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.